Ashland Global Quarterly Balance Sheets Chart
Quarterly
|
Annual
Ashland Global Quarterly Balance Sheets Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2016-12-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||
current assets | |||||||||||||||||||
cash and cash equivalents | 207,000,000 | 168,000,000 | 373,000,000 | 335,000,000 | 454,000,000 | 416,000,000 | 353,000,000 | 157,000,000 | 232,000,000 | 132,000,000 | 164,000,000 | 149,000,000 | 294,000,000 | 182,000,000 | 225,000,000 | 601,000,000 | 566,000,000 | 492,000,000 | 704,000,000 |
accounts receivable, net(a) - note h | 201,000,000 | 226,000,000 | |||||||||||||||||
inventories - note f | 567,000,000 | 542,000,000 | 512,000,000 | 537,000,000 | 617,000,000 | 611,000,000 | 633,000,000 | 595,000,000 | 599,000,000 | 619,000,000 | 656,000,000 | 649,000,000 | 674,000,000 | 631,000,000 | 666,000,000 | ||||
other assets | 149,000,000 | 139,000,000 | 86,000,000 | 100,000,000 | 87,000,000 | 121,000,000 | 119,000,000 | 53,000,000 | 64,000,000 | 47,000,000 | 63,000,000 | 62,000,000 | 74,000,000 | 144,000,000 | 122,000,000 | 92,000,000 | 91,000,000 | 73,000,000 | 106,000,000 |
total current assets | 1,124,000,000 | 1,075,000,000 | 1,418,000,000 | 1,381,000,000 | 1,547,000,000 | 1,670,000,000 | 1,645,000,000 | 1,344,000,000 | 1,433,000,000 | 2,037,000,000 | 2,087,000,000 | 1,991,000,000 | 1,712,000,000 | 1,672,000,000 | 1,713,000,000 | 1,964,000,000 | 1,903,000,000 | 1,839,000,000 | 2,334,000,000 |
noncurrent assets | |||||||||||||||||||
property, plant and equipment | |||||||||||||||||||
cost | 3,336,000,000 | 3,261,000,000 | 3,307,000,000 | 3,310,000,000 | 3,265,000,000 | 3,203,000,000 | 3,172,000,000 | 3,155,000,000 | 3,165,000,000 | 3,196,000,000 | 3,167,000,000 | 3,195,000,000 | 3,847,000,000 | 3,826,000,000 | 3,859,000,000 | 3,795,000,000 | 3,762,000,000 | 3,707,000,000 | 4,283,000,000 |
accumulated depreciation | 2,135,000,000 | 2,041,000,000 | 1,775,000,000 | 1,748,000,000 | 1,700,000,000 | 1,649,000,000 | 1,608,000,000 | 1,580,000,000 | 1,588,000,000 | 1,616,000,000 | 1,580,000,000 | 1,574,000,000 | 1,948,000,000 | 1,933,000,000 | 1,919,000,000 | 1,850,000,000 | 1,792,000,000 | 1,770,000,000 | 2,097,000,000 |
net property, plant and equipment | 1,201,000,000 | 1,220,000,000 | 1,532,000,000 | 1,562,000,000 | 1,565,000,000 | 1,554,000,000 | 1,564,000,000 | 1,575,000,000 | 1,577,000,000 | 1,580,000,000 | 1,587,000,000 | 1,621,000,000 | 1,899,000,000 | 1,893,000,000 | 1,940,000,000 | 1,945,000,000 | 1,970,000,000 | 1,937,000,000 | 2,186,000,000 |
goodwill - note g | 705,000,000 | 1,356,000,000 | 1,760,000,000 | 1,792,000,000 | 1,734,000,000 | 1,723,000,000 | 2,274,000,000 | 2,285,000,000 | 2,279,000,000 | 2,289,000,000 | 2,447,000,000 | 2,503,000,000 | 2,475,000,000 | 2,426,000,000 | 2,348,000,000 | ||||
intangibles - note g | 578,000,000 | 580,000,000 | 971,000,000 | 1,001,000,000 | 1,026,000,000 | 1,044,000,000 | 1,072,000,000 | 1,118,000,000 | 1,135,000,000 | 1,159,000,000 | 1,249,000,000 | 1,290,000,000 | 1,298,000,000 | 1,316,000,000 | 1,026,000,000 | ||||
operating lease assets, net - note i | 101,000,000 | 98,000,000 | 132,000,000 | 137,000,000 | 140,000,000 | 144,000,000 | 157,000,000 | ||||||||||||
restricted investments - note e | 283,000,000 | 272,000,000 | 302,000,000 | 316,000,000 | 297,000,000 | 277,000,000 | 314,000,000 | 310,000,000 | 296,000,000 | 279,000,000 | 304,000,000 | 303,000,000 | 315,000,000 | 299,000,000 | 297,000,000 | ||||
asbestos insurance receivable, net(b) - note l | 129,000,000 | 126,000,000 | |||||||||||||||||
deferred income taxes | 241,000,000 | 241,000,000 | 26,000,000 | 26,000,000 | 24,000,000 | 24,000,000 | 23,000,000 | 28,000,000 | 28,000,000 | 28,000,000 | 28,000,000 | 35,000,000 | 199,000,000 | ||||||
total noncurrent assets | 3,497,000,000 | 4,158,000,000 | 5,246,000,000 | 5,361,000,000 | 5,330,000,000 | 5,316,000,000 | 5,323,000,000 | 5,982,000,000 | 5,818,000,000 | 5,888,000,000 | 5,911,000,000 | 5,952,000,000 | 6,540,000,000 | 6,552,000,000 | 6,728,000,000 | 6,691,000,000 | 6,715,000,000 | 6,667,000,000 | 6,729,000,000 |
total assets | 4,621,000,000 | 5,233,000,000 | 6,664,000,000 | 6,742,000,000 | 6,877,000,000 | 6,986,000,000 | 6,968,000,000 | 7,326,000,000 | 7,251,000,000 | 7,925,000,000 | 7,998,000,000 | 7,943,000,000 | 8,252,000,000 | 8,224,000,000 | 8,441,000,000 | 8,655,000,000 | 8,618,000,000 | 8,506,000,000 | 9,063,000,000 |
liabilities and stockholders' equity | |||||||||||||||||||
current liabilities | |||||||||||||||||||
trade and other payables | 185,000,000 | 185,000,000 | 217,000,000 | 217,000,000 | 233,000,000 | 225,000,000 | 255,000,000 | 234,000,000 | 313,000,000 | 275,000,000 | 280,000,000 | 277,000,000 | 483,000,000 | 397,000,000 | 387,000,000 | 382,000,000 | 409,000,000 | 392,000,000 | 458,000,000 |
accrued expenses and other liabilities | 216,000,000 | 209,000,000 | 241,000,000 | 252,000,000 | 277,000,000 | 238,000,000 | 218,000,000 | 245,000,000 | 271,000,000 | 241,000,000 | 232,000,000 | 257,000,000 | 338,000,000 | 263,000,000 | 266,000,000 | 266,000,000 | 324,000,000 | 274,000,000 | 451,000,000 |
current operating lease obligations - note i | 19,000,000 | 19,000,000 | 23,000,000 | 23,000,000 | 23,000,000 | 23,000,000 | 24,000,000 | ||||||||||||
total current liabilities | 420,000,000 | 463,000,000 | 569,000,000 | 585,000,000 | 813,000,000 | 937,000,000 | 972,000,000 | 688,000,000 | 757,000,000 | 1,007,000,000 | 920,000,000 | 906,000,000 | 1,075,000,000 | 742,000,000 | 712,000,000 | 1,003,000,000 | 968,000,000 | 895,000,000 | 1,016,000,000 |
noncurrent liabilities | |||||||||||||||||||
long-term debt - note h | 1,382,000,000 | 1,336,000,000 | 1,571,000,000 | 1,601,000,000 | 1,547,000,000 | 1,535,000,000 | 1,502,000,000 | 2,275,000,000 | 2,275,000,000 | 2,275,000,000 | 2,450,000,000 | 2,579,000,000 | 2,584,000,000 | 2,584,000,000 | 2,825,000,000 | ||||
asbestos litigation reserve - note l | 404,000,000 | 391,000,000 | 489,000,000 | 498,000,000 | 525,000,000 | 530,000,000 | 540,000,000 | ||||||||||||
employee benefit obligations - note k | 111,000,000 | 110,000,000 | 152,000,000 | 157,000,000 | 152,000,000 | 151,000,000 | 152,000,000 | ||||||||||||
operating lease obligations - note i | 84,000,000 | 82,000,000 | 119,000,000 | 124,000,000 | 126,000,000 | 131,000,000 | 143,000,000 | ||||||||||||
other liabilities | 303,000,000 | 263,000,000 | 421,000,000 | 433,000,000 | 438,000,000 | 416,000,000 | 426,000,000 | 419,000,000 | 426,000,000 | 433,000,000 | 573,000,000 | 541,000,000 | 409,000,000 | 361,000,000 | 438,000,000 | ||||
total noncurrent liabilities | 2,312,000,000 | 2,211,000,000 | 2,981,000,000 | 3,035,000,000 | 3,028,000,000 | 3,036,000,000 | 3,013,000,000 | 3,013,000,000 | 2,923,000,000 | 3,701,000,000 | 3,716,000,000 | 3,732,000,000 | 3,771,000,000 | 4,083,000,000 | 4,218,000,000 | 4,253,000,000 | 4,244,000,000 | 4,212,000,000 | 5,046,000,000 |
commitments and contingencies - note l | |||||||||||||||||||
stockholders’ equity - note n | 1,889,000,000 | 2,559,000,000 | |||||||||||||||||
total liabilities and stockholders' equity | 4,621,000,000 | 5,233,000,000 | 6,664,000,000 | 6,742,000,000 | 6,986,000,000 | 6,968,000,000 | 7,326,000,000 | 7,925,000,000 | 7,998,000,000 | 7,943,000,000 | 8,224,000,000 | 8,441,000,000 | 8,655,000,000 | ||||||
short-term debt - note h | 50,000,000 | 85,000,000 | 93,000,000 | 446,000,000 | 471,000,000 | 179,000,000 | 332,000,000 | 261,000,000 | 229,000,000 | 82,000,000 | 59,000,000 | 355,000,000 | 223,000,000 | 92,000,000 | |||||
accounts receivable | 447,000,000 | 409,000,000 | 471,000,000 | 455,000,000 | 498,000,000 | 441,000,000 | 481,000,000 | 507,000,000 | 522,000,000 | 448,000,000 | 681,000,000 | 690,000,000 | 717,000,000 | 597,000,000 | 612,000,000 | 643,000,000 | 858,000,000 | ||
current assets held for sale - note b | 61,000,000 | 64,000,000 | 60,000,000 | ||||||||||||||||
asbestos insurance receivable (b) - note l | 128,000,000 | 130,000,000 | |||||||||||||||||
liabilities and equity | |||||||||||||||||||
current portion of long-term debt - note h | 3,000,000 | 6,000,000 | 15,000,000 | ||||||||||||||||
stockholders’ equity | 3,114,000,000 | 3,122,000,000 | 3,013,000,000 | 2,983,000,000 | 3,625,000,000 | 3,305,000,000 | 3,399,000,000 | 3,511,000,000 | |||||||||||
inventories - note a | 529,000,000 | 597,000,000 | 663,000,000 | 634,000,000 | |||||||||||||||
current assets held for sale - note c | 6,000,000 | ||||||||||||||||||
property, plant and equipment - note g | |||||||||||||||||||
goodwill - note h | 1,758,000,000 | 2,465,000,000 | |||||||||||||||||
intangibles - note h | 1,013,000,000 | 1,319,000,000 | |||||||||||||||||
operating lease assets, net - note k | 137,000,000 | ||||||||||||||||||
restricted investments - note f | 301,000,000 | 302,000,000 | |||||||||||||||||
asbestos insurance receivable - note n | 136,000,000 | 209,000,000 | |||||||||||||||||
deferred income taxes - note l | 26,000,000 | 28,000,000 | |||||||||||||||||
other assets - note j | 394,000,000 | 422,000,000 | |||||||||||||||||
short-term debt - note i | 280,000,000 | 235,000,000 | |||||||||||||||||
current operating lease obligations - note k | 23,000,000 | ||||||||||||||||||
current liabilities held for sale - note c | |||||||||||||||||||
long-term debt - note i | 1,573,000,000 | 2,584,000,000 | |||||||||||||||||
asbestos litigation reserve - note n | 513,000,000 | 694,000,000 | |||||||||||||||||
employee benefit obligations - note m | 157,000,000 | 191,000,000 | |||||||||||||||||
operating lease obligations - note k | 124,000,000 | ||||||||||||||||||
other liabilities - note j | 432,000,000 | 400,000,000 | |||||||||||||||||
commitments and contingencies - notes k and n | |||||||||||||||||||
equity - notes o and p | |||||||||||||||||||
common stock | 1,000,000 | 1,000,000 | |||||||||||||||||
issued 61 million and 60 million shares in 2020 and 2019 | |||||||||||||||||||
paid-in capital | 769,000,000 | 756,000,000 | 946,000,000 | 931,000,000 | |||||||||||||||
retained earnings | 2,649,000,000 | 3,224,000,000 | 2,750,000,000 | 2,696,000,000 | |||||||||||||||
accumulated other comprehensive loss | -383,000,000 | -410,000,000 | -291,000,000 | ||||||||||||||||
total equity | 3,036,000,000 | 3,571,000,000 | 3,406,000,000 | 3,406,000,000 | 3,399,000,000 | 3,001,000,000 | |||||||||||||
total liabilities and equity | 6,877,000,000 | 7,251,000,000 | 8,252,000,000 | 8,618,000,000 | 8,506,000,000 | 9,063,000,000 | |||||||||||||
asbestos insurance receivable - note l | 138,000,000 | 145,000,000 | 156,000,000 | ||||||||||||||||
current liabilities held for sale - note b | 5,000,000 | 5,000,000 | 6,000,000 | ||||||||||||||||
current assets held for sale - note d | 59,000,000 | ||||||||||||||||||
property, plant and equipment - note h | |||||||||||||||||||
goodwill - note i | 2,253,000,000 | 2,449,000,000 | |||||||||||||||||
intangibles - note i | 1,088,000,000 | 1,225,000,000 | |||||||||||||||||
restricted investments - note g | 310,000,000 | 312,000,000 | |||||||||||||||||
asbestos insurance receivable - note o | 157,000,000 | 179,000,000 | |||||||||||||||||
deferred income taxes - note m | 23,000,000 | 28,000,000 | |||||||||||||||||
other assets - note k | 410,000,000 | 448,000,000 | |||||||||||||||||
noncurrent assets held for sale - note d | |||||||||||||||||||
short-term debt - note j | 166,000,000 | 254,000,000 | |||||||||||||||||
current liabilities held for sale - note d | 7,000,000 | ||||||||||||||||||
long-term debt - note j | 1,501,000,000 | 2,275,000,000 | |||||||||||||||||
asbestos litigation reserve - note o | 555,000,000 | 612,000,000 | |||||||||||||||||
employee benefit obligations - note n | 150,000,000 | 179,000,000 | |||||||||||||||||
other liabilities - note k | 453,000,000 | 426,000,000 | |||||||||||||||||
noncurrent liabilities held for sale - note d | |||||||||||||||||||
commitments and contingencies - notes l and o | |||||||||||||||||||
equity - notes p and q | |||||||||||||||||||
issued 60 million and 62 million shares in 2019 and 2018 | |||||||||||||||||||
held for sale - note b | 756,000,000 | 739,000,000 | 713,000,000 | ||||||||||||||||
asbestos insurance receivable - note k | 161,000,000 | 175,000,000 | 178,000,000 | 181,000,000 | 203,000,000 | 205,000,000 | 211,000,000 | 194,000,000 | |||||||||||
asbestos litigation reserve - note k | 576,000,000 | 587,000,000 | 594,000,000 | 631,000,000 | 665,000,000 | 676,000,000 | 702,000,000 | 674,000,000 | |||||||||||
employee benefit obligations - note j | 147,000,000 | 145,000,000 | 145,000,000 | 186,000,000 | 190,000,000 | 194,000,000 | 191,000,000 | 1,040,000,000 | |||||||||||
commitments and contingencies - note k | |||||||||||||||||||
stockholders’ equity - note m | 3,217,000,000 | 3,362,000,000 | |||||||||||||||||
issued 62 million shares in 2018 and 2017 | 1,000,000 | ||||||||||||||||||
deferred and other income taxes | 28,000,000 | 28,000,000 | |||||||||||||||||
stockholders' equity | 3,399,000,000 | 3,399,000,000 | |||||||||||||||||
current assets of discontinued operations - note e | |||||||||||||||||||
noncurrent assets of discontinued operations - note e | |||||||||||||||||||
current liabilities of discontinued operations - note e | |||||||||||||||||||
noncurrent liabilities of discontinued operations - note e | |||||||||||||||||||
issued 62 million shares in 2017 and 2016 | 1,000,000 | ||||||||||||||||||
total ashland stockholders’ equity | 3,406,000,000 | ||||||||||||||||||
noncontrolling interest | |||||||||||||||||||
current assets of discontinued operations - note d | |||||||||||||||||||
equity and other unconsolidated investments | 32,000,000 | 60,000,000 | |||||||||||||||||
noncurrent assets of discontinued operations - note d | |||||||||||||||||||
current liabilities of discontinued operations - note d | |||||||||||||||||||
noncurrent liabilities of discontinued operations - note d | |||||||||||||||||||
equity | |||||||||||||||||||
total ashland stockholders' equity | 3,175,000,000 |
We provide you with 20 years of balance sheets for Ashland Global stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Ashland Global. Explore the full financial landscape of Ashland Global stock with our expertly curated balance sheets.
The information provided in this report about Ashland Global stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.